El año pasado, Enovis Corp generó 1.14B USD en su segmento con mejor rendimiento, Medical Technology-Prevention & Rehabilitation. United States realizó la mayor aportación, representando 1.30B USD el año pasado.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Medical Technology-Prevention & Rehabilitation

Medical Technology-Reconstructive

U.S. Reconstructive

International Reconstructive

U.S. Bracing & Support

International P&R

U.S. Other P&R

Fabrication Technology-Consumables

Fabrication Technology-Equipment

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Medical Technology-Prevention & Rehabilitation

1.14B(50.58%)

1.10B(26.05%)

1.08B(63.07%)

1.03B(65.74%)

1.03B(26.62%)

781.01M(25.43%)

766.43M(23.03%)

Medical Technology-Reconstructive

1.11B(49.42%)

1.01B(23.95%)

630.42M(36.93%)

535.47M(34.26%)

400.16M(10.38%)

339.69M(11.06%)

314.00M(9.44%)

U.S. Reconstructive

--(--)

505.62M(12.00%)

--(--)

International Reconstructive

--(--)

504.05M(11.96%)

--(--)

U.S. Bracing & Support

--(--)

469.31M(11.13%)

--(--)

International P&R

--(--)

357.90M(8.49%)

--(--)

U.S. Other P&R

--(--)

270.74M(6.42%)

--(--)

Fabrication Technology-Consumables

--(--)

1.67B(43.32%)

1.34B(43.72%)

1.54B(46.40%)

Fabrication Technology-Equipment

--(--)

758.27M(19.67%)

607.50M(19.78%)

703.02M(21.13%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

Other Foreign locations

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

United States

1.30B(57.62%)

1.25B(59.10%)

1.15B(67.50%)

1.06B(67.99%)

1.56B(40.58%)

1.28B(41.80%)

1.46B(44.00%)

540.53M(24.65%)

Other Foreign locations

952.72M(42.38%)

861.95M(40.90%)

554.84M(32.50%)

500.34M(32.01%)

2.29B(59.42%)

1.79B(58.20%)

1.86B(56.00%)

1.65B(75.35%)